Hexo (TSE:HEXO) had its price target upped by stock analysts at BMO Capital Markets from C$6.00 to C$9.00 in a report issued on Friday. BMO Capital Markets’ price target would suggest a potential upside of 11.11% from the company’s previous close.

Several other equities research analysts have also recently commented on the company. Jefferies Financial Group reissued an “underperform” rating and issued a C$5.60 price target on shares of Hexo in a research note on Monday, February 25th. CIBC reissued an “outperform” rating and issued a C$8.50 price target on shares of Hexo in a research note on Tuesday, February 19th. Finally, Oppenheimer began coverage on Hexo in a research note on Tuesday, February 19th. They issued an “outperform” rating and a C$7.00 price target for the company.

Shares of TSE HEXO opened at C$8.10 on Friday. The company has a market capitalization of $1.68 billion and a P/E ratio of -38.21. Hexo has a 52 week low of C$3.34 and a 52 week high of C$9.29.

Hexo Company Profile

HEXO Corp., through its subsidiary, HEXO Operations Inc, produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names.

Featured Article: What is insider trading?

Receive News & Ratings for Hexo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hexo and related companies with MarketBeat.com's FREE daily email newsletter.